Well Health Technologies (TSE:WELL) has released an update.
WELL Health Technologies, in partnership with HEALWELL AI, has unveiled an advanced AI-powered decision support tool that now includes screening for chronic diseases like kidney disease, hypertension, and diabetes. This innovation aims to revolutionize patient care by enabling early detection and risk stratification of over a hundred diseases, which could lead to better management of Canada’s annual $190 billion chronic disease-related costs. The second-generation tool, designed to assist healthcare providers at the point of care, marks a significant leap in combining data science with clinical expertise to improve patient outcomes.
For further insights into TSE:WELL stock, check out TipRanks’ Stock Analysis page.
